Scarica l'app Stockscreener
1.13
2.73%
0.03
Dopo l'orario di chiusura:
1.11
-0.02
-1.77%
Precedente Chiudi:
$1.10
Aprire:
$1.13
Volume 24 ore:
98,310
Relative Volume:
0.29
Capitalizzazione di mercato:
$20.74M
Reddito:
-
Utile/perdita netta:
$-33.08M
Rapporto P/E:
-0.3844
EPS:
-2.94
Flusso di cassa netto:
$-25.68M
1 W Prestazione:
-11.72%
1M Prestazione:
-30.25%
6M Prestazione:
-26.62%
1 anno Prestazione:
+45.06%
Intervallo 1D:
$1.07
$1.14
Intervallo di 1 settimana:
$0.99
$1.35
Portata 52W:
$0.579
$2.55
Chemomab Therapeutics Ltd Adr Stock (CMMB) Company Profile
Nome
Chemomab Therapeutics Ltd Adr
Settore
Industria
Telefono
972-77-331-0156
Indirizzo
KIRYAT ATIDIM, BUILDING 7, TEL AVIV
Confronta CMMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMMB
Chemomab Therapeutics Ltd Adr
|
1.13 | 20.74M | 0 | -33.08M | -25.68M | -2.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-13 | Iniziato | Maxim Group | Buy |
| 2024-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-12-19 | Ripresa | ROTH MKM | Buy |
Chemomab Therapeutics Ltd Adr Borsa (CMMB) Ultime notizie
The Aurora Cannabis Inc (NASDAQ: ACB) Stock Price: Is It Overvalued? - Stocks Register
How Stable And Growing Is Globavend Holdings Ltd (NASDAQ: GVH)? - Stocks Register
Before Buying AYRO Inc (NASDAQ: AYRO) Stock, Read This First - Stocks Register
Warner Bros. Discovery Inc (NASDAQ: WBD): An Enticing Stock To Watch - Stocks Register
Nu Holdings Ltd (NYSE: NU) Has Great Upside Potential - Stocks Register
Metrics That Matter About Atlassian Corporation (NASDAQ: TEAM) - Stocks Register
AT&T, Inc (NYSE: T) Jumps 1.59%: What Could Be On The Way Going Forward? - Stocks Register
Adma Biologics Inc (NASDAQ: ADMA): Blank Check For Growth? - Stocks Register
A Bullish 2025 Outlook For Blink Charging Co (NASDAQ: BLNK) Shares - Stocks Register
In 2025, Linkers Industries Ltd (NASDAQ: LNKS) Shares Will Likely Be Bullish - Stocks Register
Carrier Global Corp (NYSE: CARR): On Track To A Higher Share Price - Stocks Register
Ally Financial Inc (NYSE: ALLY): An Enticing Stock To Watch - Stocks Register
Does DLocal Limited (NASDAQ: DLO) Still Need To Convince Analysts? - Stocks Register
Think You Need A Good Stock? Look At This Scilex Holding Company (NASDAQ: SCLX) Analysis - Stocks Register
Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - Stocks Register
Chemomab Therapeutics (CMMB) Stock Price, News & Analysis - MarketBeat
How analysts predict Chemomab Therapeutics Ltd ADR (CMMB) will perform this quarter? - US Post News
LogicMark Inc (LGMK) Recovers 0.71% From Low: Are We There Yet? - Stocks Register
Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis - GlobeNewswire Inc.
Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Investing.com
Chemomab reports progress in PSC treatment trial - Investing.com
Roth MKM Initiates Coverage of Chemomab Therapeutics LtdADR (CMMB) with Buy Recommendation - MSN
The Chemomab Therapeutics Ltd ADR (CMMB) had a good session last reading, didn’t it? - US Post News
Ratios Uncovered: Breaking Down Chemomab Therapeutics Ltd ADR (CMMB)’s Trailing Twelve Months Metrics - The Dwinnex
symbol__ Stock Quote Price and Forecast - CNN
Intercept (ICPT) Gains 12.4% in the Past Six Months: Here's Why - Zacks Investment Research
Chemomab And AGC Biologics Partner To Manufacture CM-101 For Phase II/III - Contract Pharma
What You Need To Know About Chemomab Therapeutics Ltd.'s (NASDAQ:CMMB) Investor Composition - Yahoo Finance
CMMB News Today | Why did Chemomab Therapeutics stock go down today? - MarketBeat
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal - Yahoo Finance
Chemomab Therapeutics Ltd Adr Azioni (CMMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):